Article ID Journal Published Year Pages File Type
915851 Revista Internacional de Andrología 2016 6 Pages PDF
Abstract
We suggest a PSA index of 17% as cut-off point to discriminate between benign prostatic hyperplasia and prostate cancerin the urology outpatient consult of patients with a total PSA between 4.0 ng/ml and 9.9 ng/ml. We recommend this value as it could reduce the number of negative biopsies.
Related Topics
Health Sciences Medicine and Dentistry Surgery
Authors
, , ,